Benjamin Edwards Inc’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-32
Closed – – 1195
2024
Q2
$0 Sell
32
-538
-94% -$6.56K ﹤0.01% 771
2024
Q1
$9K Sell
570
-93
-14% -$1.69K ﹤0.01% 647
2023
Q4
$14K Sell
663
-433
-40% -$7.99K ﹤0.01% 568
2023
Q3
$20K Buy
1,096
+34
+3% +$794 ﹤0.01% 533
2023
Q2
$27K Buy
1,062
+38
+4% +$956 0.01% 520
2023
Q1
$27K Buy
1,024
+97
+10% +$2.6K 0.01% 515
2022
Q4
$22K Buy
927
+193
+26% +$5.2K 0.01% 501
2022
Q3
$19K Sell
734
-16
-2% -$561 0.01% 511
2022
Q2
$25K Sell
750
-261
-26% -$11.1K 0.01% 499
2022
Q1
$73K Buy
1,011
+341
+51% +$24.6K 0.02% 414
2021
Q4
$62K Buy
670
+145
+28% +$17.3K 0.02% 401
2021
Q3
$67K Buy
525
+33
+7% +$4.8K 0.04% 266
2021
Q2
$82K Buy
492
+68
+16% +$11K 0.06% 235
2021
Q1
$77K Buy
424
+134
+46% +$31.1K 0.06% 226
2020
Q4
$58K Buy
290
+125
+76% +$25.4K 0.05% 239
2020
Q3
$36K Buy
165
+133
+416% +$28.2K 0.03% 246
2020
Q2
$6K Sell
32
-13
-29% -$2.28K 0.01% 330
2020
Q1
$7K Sell
45
-103
-70% -$12K 0.01% 306
2019
Q4
$12K Sell
148
-19
-11% -$1.45K 0.02% 215
2019
Q3
$11K Buy
167
+18
+12% +$1.19K 0.02% 216
2019
Q2
$10K Buy
149
+72
+94% +$4.2K 0.02% 218
2019
Q1
$4K Buy
+77
New +$4.7K 0.02% 254

Other funds holding TDOC

Benjamin Edwards Inc's TDOC Position: Q3 2024 in Review

Benjamin Edwards Inc sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 32 shares.

Benjamin Edwards Inc first reported a position in TDOC in Q1 2019 and held it in 22 quarters. The position peaked at $82K in Q2 2021. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Benjamin Edwards Inc reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Benjamin Edwards Inc sold 32 Teladoc Health shares in Q3 2024.
  • Benjamin Edwards Inc first reported a position in Teladoc Health in Q1 2019 and held it in 22 quarters.
  • Benjamin Edwards Inc's Teladoc Health position peaked at $82K in Q2 2021.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Benjamin Edwards Inc's 13F filing for Q3 2024, filed 14 Nov 2024.